| Effect | Decrease |
| Trial Design | Cohort |
| Trial Length | 1-6 months |
| Number of Subjects | 50 |
| Sex | Female |
| Age Range | 30-44 |
| Body Types | Average |
Supplementation of inositol in young women with PCOS (of which hirstuism and acne are common side effects) was therapeutic over the course of six months of treatment at 2,000mg.
Acne at baseline was either moderate (68%) or severe (32%) and, after supplementation, it was reduced respectively to 34% and 13% with more than half the sample (53%) noting an abolishment of all acne.
No placebo control group was used.
